ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 14 of 42 for:    Recruiting, Not yet recruiting, Available Studies | "Spondylolisthesis"

Comparative Study Between Posterior Lumbar Interbody Fusion(PLIF) and Intertransverse Process Fusion in Treatment of Spodylolithesis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03271060
Recruitment Status : Not yet recruiting
First Posted : September 1, 2017
Last Update Posted : September 1, 2017
Sponsor:
Information provided by (Responsible Party):
Mahmoud Garamoun Abd El Zaher, Assiut University

Brief Summary:

The first technique described for interbody fusion was the anterior lumbar interbody fusion (ALIF).(20) For this technique, the intervertebral disc is accessed through a retroperitoneal or transperitoneal approach.

While the posterior approach was first described by Russell Hibbs in 1911, in the 1950's, Cloward (7)popularized the posterior approach for a posterior lumbar interbody fusion (PLIF).


Condition or disease Intervention/treatment Phase
Lumbar Spondylolisthesis Procedure: Posterior lumbar interbody fusion Procedure: Inter transverse bone grafting Not Applicable

Detailed Description:
In this study we will try to identify the benefits and outcome of posterior lumbar interbody fusion and inter transverse process bone graft fusion.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Intervention Model Description: Posterior inter body fusion and inter transverse process bone graft
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Comparative Study Between Posterior Lumbar Interbody Fusion(PLF) and Intertransverse Process Fusion in Treatment of Spodylolithesis
Estimated Study Start Date : September 1, 2017
Estimated Primary Completion Date : August 30, 2018
Estimated Study Completion Date : September 1, 2019

Arm Intervention/treatment
Active Comparator: Lumbar spondylolisthesis1 Procedure: Inter transverse bone grafting
Inter transverse process bone grafting by bone graft from illiac crest or other sites

Active Comparator: Lumbar spondylolisthesis 2 Procedure: Posterior lumbar interbody fusion
Lumbar fusion by screws and inter vertebral cage




Primary Outcome Measures :
  1. Back pain [ Time Frame: 1year postoperative ]
    Back pain severity grading mild, moderate, severe



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • lumbar spondylolisthesis

Exclusion Criteria:

  • infection of lumbar spine

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03271060


Contacts
Contact: Mahmoud Garamoun, Resident 201091123869 Garamoun.mahmoud@yahoo.com

Sponsors and Collaborators
Assiut University

Responsible Party: Mahmoud Garamoun Abd El Zaher, Doctor, Assiut University
ClinicalTrials.gov Identifier: NCT03271060     History of Changes
Other Study ID Numbers: Lumbar spondylolisthesis
First Posted: September 1, 2017    Key Record Dates
Last Update Posted: September 1, 2017
Last Verified: August 2017

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Spondylolisthesis
Spondylolysis
Spondylosis
Spinal Diseases
Bone Diseases
Musculoskeletal Diseases